The Synthims2019 Organizing Committee welcomes you to attend the conference "Synthetic and Systems Immunology Conference 2019", which will be held from 5. to 8. May, 2019 at the Congressi Stefano Franscini, Monte Verità, Ascona, Switzerland.
Benefitting from tremendous advances in large-scale ‘omics’ technologies, immune phenotyping and genome engineering, novel integrated workflows are providing unprecedented insights into the networks, pathways and systems that govern human health and disease, thus enabling their successful therapeutic manipulation. The conference will begin with insights into recent strategies and concepts in the area of therapeutic protein engineering, rational vaccine design and -delivery.
Next, advances in high-throughput methods such as (single-cell) sequencing and microfluidics will be discussed which devise general construction principles of the adaptive immune system and provide information on immune status upon perturbation, as well as on potential disease-specific biomarkers. The meeting will then move on to shed light on the potential and risks of adoptive immune cell transfer therapies that are on the rise due to the current revolution in precise genome engineering. Critical to clinical progress is the translation of foundational synthetic and systems immunology research into novel therapies. A dedicated session centered on that topic in the field of cancer immunotherapy and infectious diseases will conclude the meeting.
The conference will be limited to a maximum of 120 participants (including invited speakers and organizers). In case of overbooking, participants with an accepted abstract will have priority.
New abstract submission deadline: 1. April 2019.
The preliminary program is available here.
Confirmed invited speakers
- Davide Angeletti, University of Gothenburg, Sweden
- Ron Germain, NIH, USA
- Ning Jenny Jiang, University of Texas, USA
- Johanna Olweus, Institute of Clinical Medicine, Norway
- Mark Rubin, University of Berne, Switzerland
- William Schief, The Scripps Research Institute, USA
- Kathrin Schumann, Technical University of Munich, Germany
- Melody Swartz, University of Chicago, USA
- Alfred Zippelius, University Hospital Basel, Switzerland